Vertex Pharmaceuticals Incorporated (LON: 0QZU)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 23, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Market Capitalization	81,375	82,315	61,522	41,234	45,014	42,512
Market Cap Growth	21.77%	33.80%	49.20%	-8.40%	5.89%	27.94%
Enterprise Value	73,856	72,200	54,097	36,741	40,909	39,985
Last Close Price	319.16	319.55	236.58	163.63	171.91	165.73
PE Ratio	-	28.97	22.31	23.84	22.66	47.84
PS Ratio	11.30	10.62	8.30	7.37	9.90	13.53
PB Ratio	7.68	5.96	5.33	5.53	7.07	9.25
P/TBV Ratio	8.75	6.70	6.07	6.42	8.44	12.02
P/FCF Ratio	-	31.42	18.88	23.18	20.53	37.69
P/OCF Ratio	-	29.64	17.95	21.12	18.89	35.88
EV/Sales Ratio	8.74	9.32	7.30	6.57	9.00	12.72
EV/EBITDA Ratio	20.63	20.54	14.40	12.38	17.66	40.46
EV/EBIT Ratio	21.91	21.35	14.89	12.78	18.29	44.06
EV/FCF Ratio	-89.52	27.56	16.61	20.66	18.66	35.45
Debt / Equity Ratio	0.11	0.05	0.06	0.10	0.11	0.11
Debt / EBITDA Ratio	0.39	0.18	0.20	0.24	0.30	0.51
Debt / FCF Ratio	-	0.24	0.23	0.40	0.31	0.45
Asset Turnover	0.48	0.48	0.57	0.60	0.62	0.57
Inventory Turnover	5.58	7.38	8.87	8.97	10.62	15.78
Quick Ratio	2.08	3.60	4.46	4.04	4.02	3.33
Current Ratio	2.47	3.99	4.83	4.46	4.33	3.61
Return on Equity (ROE)	-2.99%	22.99%	27.67%	24.93%	36.71%	22.37%
Return on Assets (ROA)	12.05%	13.17%	17.33%	19.32%	19.02%	10.32%
Return on Capital (ROIC)	15.29%	16.22%	21.15%	23.51%	23.30%	12.75%
Earnings Yield	-0.44%	3.45%	4.48%	4.19%	4.41%	2.09%
FCF Yield	-0.92%	3.18%	5.30%	4.31%	4.87%	2.65%
Buyback Yield / Dilution	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%
Total Shareholder Return	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%

Source: S&P Capital IQ. Standard template. Financial Sources.